User profiles for Andrew Kambugu

Andrew Kambugu

Infectious Diseases Institute
Verified email at idi.co.ug
Cited by 8431

Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy

A Kambugu, DB Meya, J Rhein… - Clinical infectious …, 2008 - academic.oup.com
Background . Cryptococcal meningitis (CM) is the proximate cause of death in 20%–30% of
persons with acquired immunodeficiency syndrome in Africa. Methods . Two prospective, …

[HTML][HTML] Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis

…, K Nielsen, TL Bergemann, A Kambugu… - … England Journal of …, 2014 - Mass Medical Soc
Background Cryptococcal meningitis accounts for 20 to 25% of acquired immunodeficiency
syndrome–related deaths in Africa. Antiretroviral therapy (ART) is essential for survival; …

Retention in care among HIV-infected patients in resource-limited settings: emerging insights and new directions

EH Geng, D Nash, A Kambugu, Y Zhang… - Current Hiv/aids …, 2010 - Springer
In resource-limited settings—where a massive scale up of HIV services has occurred in the
last 5 years—both understanding the extent of and improving retention in care presents …

Cost-Effectiveness of Serum Cryptococcal Antigen Screening to Prevent Deaths among HIV-Infected Persons with a CD4+ Cell Count ≤100 Cells/μL Who Start HIV …

…, BA Cook, AM Elbireer, A Kambugu… - Clinical infectious …, 2010 - academic.oup.com
Background. Cryptococcal meningitis (CM) remains a common AIDS-defining illness in Africa
and Asia. Subclinical cryptococcal antigenemia is frequently unmasked with antiretroviral …

[HTML][HTML] Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after cryptococcal meningitis: a prospective cohort study

…, J Rhein, A Musubire, SJ Lee, A Kambugu… - PLoS …, 2010 - journals.plos.org
Background Although antiretroviral therapy (ART) improves survival in persons with
cryptococcal meningitis (CM) and AIDS, ART frequently elicits HIV immune reconstitution …

[HTML][HTML] Assessment of second-line antiretroviral regimens for HIV therapy in Africa

…, C Kityo, A Hoppe, A Reid, A Kambugu… - New England journal …, 2014 - Mass Medical Soc
Background The efficacy and toxic effects of nucleoside reverse-transcriptase inhibitors (NRTIs)
are uncertain when these agents are used with a protease inhibitor in second-line …

[HTML][HTML] Dolutegravir or darunavir in combination with zidovudine or tenofovir to treat HIV

…, B Castelnuovo, A Kiragga, A Kambugu - … England Journal of …, 2021 - Mass Medical Soc
Background The World Health Organization recommends dolutegravir with two nucleoside
reverse-transcriptase inhibitors (NRTIs) for second-line treatment of human …

Predictors of long-term viral failure among ugandan children and adults treated with antiretroviral therapy

MR Kamya, H Mayanja-Kizza, A Kambugu… - JAIDS Journal of …, 2007 - journals.lww.com
Background: HIV RNA viral load testing is costly and is generally unavailable in resource-limited
settings. We identified predictors of viral failure and documented genotypic mutations in …

Severe renal dysfunction and risk factors associated with renal impairment in HIV-infected adults in Africa initiating antiretroviral therapy

…, C Kityo, P Hughes, A Kambugu… - Clinical infectious …, 2008 - academic.oup.com
Background . We sought to investigate renal function in previously untreated symptomatic
human immunodeficiency virus (HIV)–infected adults with CD4 + cell counts of <200 cells/mm …

Paucity of initial cerebrospinal fluid inflammation in cryptococcal meningitis is associated with subsequent immune reconstitution inflammatory syndrome

…, DL Wiesner, GS Park, A Kambugu… - The Journal of …, 2010 - academic.oup.com
Background. Cryptococcal meningitis (CM)-related immune reconstitution inflammatory
syndrome (IRIS) complicates antiretroviral therapy (ART) in 20%–40% of ART-naive persons …